Join industry experts for an open discussion focused on these key issues in national healthcare strategy:

• What does “wired healthcare” mean in terms of policy and impact to Pharma and other industry players?
• Where are we on the wired healthcare roadmap?
• What is controversial or causing friction among healthcare entities?
• What’s coming next, and what’s likely getting deferred?